SCHEMBL23080997

SCHEMBL23080997

CN1CCN=C1c1ccc(C(C)(C)C)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTAFR P25105 5/20 0.49
HTR1D P28221 2/20 0.45
ADRA1A P35348 1/20 0.45
NISCH Q9Y2I1 1/20 0.45
ADRA2A P08913 1/20 0.43
ADRA2B P18089 1/20 0.43
ADRA2C P18825 1/20 0.43
KIF11 P52732 1/20 0.41
SIGMAR1 Q99720 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
POLB P06746 1/20 0.38
HPGD P15428 1/20 0.38
ALOX15 P16050 1/20 0.38
HSD17B10 Q99714 1/20 0.38
APOBEC3G Q9HC16 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
TOP2A P11388 1/20 0.37
TOP2B Q02880 1/20 0.37
NPC1 O15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14085132 0.87 TOP2A (0.44) TOP2ATOP2B
SCHEMBL8286902 0.79 PTAFR (0.46) PTAFRNISCHALDH1A1TOP2ATOP2B
Water SCHEMBL9451270 0.76 PTAFR (0.43) PTAFRTOP2ATOP2B
Hydrochloric Acid SCHEMBL6766285 0.76 TOP2A (0.41) TOP2ATOP2B
Water SCHEMBL9451273 0.76 PTAFR (0.43) PTAFRTOP2ATOP2B
SCHEMBL6871687 0.74 ALDH1A1 (0.42) KDM4EALDH1A1HPGDTOP2ATOP2B
SCHEMBL6871684 0.74 MAOB (0.38) TOP2ATOP2B
SCHEMBL7499586 0.71 SIRT6 (0.45) ALDH1A1POLBHPGDHSD17B10NPC1
SCHEMBL8289010 0.70 HPGDS (0.38)
Hydrochloric Acid SCHEMBL6765057 0.70 SIRT6 (0.44) ALDH1A1POLBHPGDHSD17B10NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210070748-A1 INHIBITORS OF BRUTONS TYROSINE KINASE PHARMACYCLICS LLC (US) 2021-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210070748-A1 INHIBITORS OF BRUTONS TYROSINE KINASE BTK, LYN, LCK PTAFR 941/4885HTR1D 4104/4885ADRA1A 4685/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.